prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, Provider Group. Date UI service: Date Received: A copy of this report will be faxed to: FINAL SURGICAL PATHOLOGY REPORT. Diagnosis: A. -C.) RIGHT BREAST AND AXILLARY SENTINEL LYMPH NODES, LUMPECTOMY WITH. SENTINEL LYMPH NODE BIOPSIES (X2): - Invasive ductal carcinoma, Nottingham grade 3. - Tumor size: 3.8 cm in diameter. - Ductal carcinoma in situ (DCIS), high nuclear grade, solid type, with. comedo necrosis and calcifications. - DCIS is present in association with invasive carcinoma, at the periphery of the. main tumor mass, does not extend significantly beyond the area of invasion,. and comprises less than 10% ofitumor volume. - Lumpectomy margins are free of tumor. - Carcinoma is located 0.3 cm from deep margin, and is at least 0.5 cm from. all other margins. - Metastatic carcinoma identified in one of two sentinel lymph nodes (the involved. lymph node is sentinel lymph node with count 414). - The metastatic focus measures 1.2 cm in diameter; no extranodal extension. is identified. - Metastatic carcinoma comprises approximately 40% of the involved. lymph node volume. PATHOLOGIC TUMOR STAGING SYNOPSIS: Type and grade (invasive): Invasive ductal carcinoma, Nottingham grade 3. Type and grade (in situ): DCIS, nuclear grade 3. Primary tumor: pT2. Regional lymph nodes: pN1a. Distant metastasis; Not applicable. Stage: IIB. Lymphovascular invasion: Present. Margin status: Negative (R0). Breast Invasive Tumor Staging Information. Printed: This report continues (FINAL). Pathology Repor. Specimen type: Partial breast. Specimen procedure: Lumpectomy. Lymph node sampling: Sentinel lymph nodes. Specimen integrity: Intact specimen. Specimen laterality: Right. Specimen size: 6.5 x 5.5 x 4.5 cm. INVASIVE TUMOR FEATURES: Invasive tumor size: 3.8 cm. Invasive tumor site: Upper-outer quadrant. Invasive tumor focality: Single focus. Histologic type: invasive ductat carcinoma. Total Noltingham Grade: 3 of 3. Tubule formation: 3 of 3,. Nuclear Pleomorphism: 3 of 3. Mitotic count for Nottingham: 3 of 3. Milotic count: Twenly-four miloses in ten high power fields. Lymphatic invasion: Present. MARGIN STATUS FOR INVASIVE COMPONENT: Negative (R0). Distance of lumor from margins: 0.3 cm. Closest margin: Deep. Other margins: All other margins are at least 0.5 cm from tumor. IN-SITU CARCINOMA (DCIS) FEATURES: DCIS extent: Comprises less than 10% of tumor volume;. DCIS identified only, in area of invasive. carcinoma. Pattern: Solid. Nuclear grade: High grade. Necrosis;. Present. Calcifications: Present. ;. Margin status for DCIS component: Negative. Distance of In-situ from nearest margin: At teast 0.5 cm. LOBULAR CARCINOMA IN-SITU (LCIS): Absent. Skin: Not applicable. Nipple: Not applicable. Skeletal Muscle: Not applicable. INVASIVE PATHOLOGIC TUMOR STAGING (pTNM). Primary tumor (pT): pT2. Regional lymph nodes (pN): pN1a. Printed;. This report continues (FINAL). /. FINAL SURGICAL PATHOLOGY REPORT. Distant melastasis (pM): Not applicable. RECEPTOR STATUS AND HER2/NEU: Estrogen receptors: 0% positive cells. Progesterone receptors: 0% positive cells. Her2/neu: Ki-67 proliferative Index: 70% positive cells. Source of Specimen: A. Breast lumpectomy;Right Breast. B. Sentinel lymph node;Right Breast. C. Sentinel lymph node;Right Breast. Clinical History/Operative Dx: Right breast mass/cancer. Gross Description: A. Specimen is labeled right breast lumpectomy. Initially received in fresh state for possible tumor bank. studies is a 74 gram portion of yellow-tan fibrofatly soft tissue, 4.5 cm anterior-posterlor,5.5.5 cm. superior-inferior. 6.5 cm medial-lateral. Three sets of sutures are present designated asifollows: a double. long designated inferior, a single long designated medial, a double short designated antérior. The. margins are now differentially inked. The specimen is serially sectioned perpendicularly through the. medial-lateral long axis to reveal a partially well demarcated dense gray-tan túmor massi measuring. upwards of 3.8 x 2.8 x2.1 cm. The mass approaches within 0.3 cm of the posterior, 0,6 cm of the medial,. 0.6 cm of the superior, 0.6 cm of the anterior, 1.0 cm of the lateral and 1.2 cm of the inferior surgical. margins. The cut surfaces surrounding the tumor mass are lobular, admixed yellow-tan without additional. discrete nodularity. Representative sections are submitted in 8 sequential fashion, lateral towards medial. Cassette summary: A1-A2) slab 1, lateral margin. This report continues.. (FINAL). Printed: FINAL SURGICAL PATHOLOGY REPORT. A3) slab 2, posterior anterior margins. A4) slab 2, superior inferior margins. A5) slab 2, bulk of tumor. A6) slab 3, posterior anterior margins, tumor. A7) slab 3, superior inferior margins, tumor. A8) slab 3, bulk of tumor. A9) slab 4, posterior margin. A10) slab 5, posterior anterior margins. A11) slab 5, superior inferior margins. A12) slab 5, bulk of tumor. A13) slab 6. posterior anterior. A14) slab 6, superior inferior margins. A15) slab 6, bulk of tumor. A16-A17) slab 7, medial margin, tumor. SUPERIOR: BLUE. MEDIAL: RED. ANTERIOR: YELLOW. INFERIOR: GREEN. LATERAL: ORANGE. POSTERIOR: SLACK. B. Specimen is labeled sentinel node right breast. Received in formalin is a rubbery pink and tan. lymph node candidate 1.3 x 1.1 x 0.7 cm. The margins are now routinely marked blue: The specimen is. serially sectioned demonstrating a rubbery pink and tan cut surface without grossly discrete nodularity. The lymph node is entirely submitted for microscopic evaluation in B1, with à sentinel lymph node. protocol performed. C. Specimen is labeled sentinel node. right breast. Received in formalin is a 3.0 x 2.3 x 2.0 cm. portion of fat. Examination reveals a 2.0 x 1.6 x 1.3 cm lymph node. The margins are now marked blue. The specimen is serially sectioned, revealing a predominantly nodular densé gray-lan dut surface with. peripheral softened pink and tan appearance. The lymph node is entirely submitted for microscopic. evaluation in C1 and C2, with a sentinel lymph node protocol performed. Microscopic Description: A. Microscopic sections have been examined. The microscopic findings are reflected In the diagnosis. rendered. 8. Microscopic sections have been examined. The microscopic findings are reflected nithe dlagnosis. rendered. C. Microscopic sections have been examined. The microscopic findings are reflected in the diagnosis. rendered. Printed: Pathology Repor.

expanded version (tokens=2006) : 
 Histological classification:
- Invasive ductal carcinoma, Nottingham grade 3
- Ductal carcinoma in situ (DCIS), high nuclear grade, solid type with comedo necrosis and calcifications

Subtype:
- Basal

Necrosis:
- Comedo necrosis present in DCIS

Tumor infiltrating lymphocytes:
- Not mentioned

Histological grade:
- Invasive carcinoma - Nottingham grade 3 (3 of 3 for tubule formation, nuclear pleomorphism and mitotic count)
- DCIS - High nuclear grade 3

Nuclear grade:
- High nuclear grade 3 in DCIS

Lymphovascular invasion:
- Present

Calcification:
- Present in DCIS

Receptor status:
- Estrogen receptors and progesterone receptors: 0% positive cells
- Her2/neu: Not mentioned
- Ki-67 proliferative index: 70% positive cells

Ancillary testing results:
- Not mentioned

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2156) : 
 The right breast lumpectomy indicated basal subtype invasive ductal carcinoma (Nottingham grade 3), with co-existing high nuclear grade Ductal carcinoma in situ that showed solid features and extensive Necrosis. Additionally, Lymphovascular invasion and Calcifications were present in the pathology. Estrogen receptors and progesterone receptors were absent. Ancillary testing results were not provided. The tumor was classified as Stage IIB, with a pT2 primary tumor and pN1a regional lymph node involvement.

